80 related articles for article (PubMed ID: 18950629)
41. Genetic deletion of PKR abrogates TNF-induced activation of IkappaBalpha kinase, JNK, Akt and cell proliferation but potentiates p44/p42 MAPK and p38 MAPK activation.
Takada Y; Ichikawa H; Pataer A; Swisher S; Aggarwal BB
Oncogene; 2007 Feb; 26(8):1201-12. PubMed ID: 16924232
[TBL] [Abstract][Full Text] [Related]
42. Fucoidan/FGF-2 induces angiogenesis through JNK- and p38-mediated activation of AKT/MMP-2 signalling.
Kim BS; Park JY; Kang HJ; Kim HJ; Lee J
Biochem Biophys Res Commun; 2014 Aug; 450(4):1333-8. PubMed ID: 25003321
[TBL] [Abstract][Full Text] [Related]
43. Ras/ERK signalling in cannabinoid tolerance: from behaviour to cellular aspects.
Rubino T; Forlani G; Viganò D; Zippel R; Parolaro D
J Neurochem; 2005 May; 93(4):984-91. PubMed ID: 15857401
[TBL] [Abstract][Full Text] [Related]
44. Oncostatin M-induced activation of stress-activated MAP kinases depends on tyrosine 861 in the OSM receptor and requires Jak1 but not Src kinases.
Böing I; Stross C; Radtke S; Lippok BE; Heinrich PC; Hermanns HM
Cell Signal; 2006 Jan; 18(1):50-61. PubMed ID: 15935618
[TBL] [Abstract][Full Text] [Related]
45. Tyrosine kinase-independent activation of extracellular-regulated kinase (ERK) 1/2 by the insulin-like growth factor-1 receptor.
Perrault R; Wright B; Storie B; Hatherell A; Zahradka P
Cell Signal; 2011 Apr; 23(4):739-46. PubMed ID: 21215800
[TBL] [Abstract][Full Text] [Related]
46. Apical expression of human full-length hCEACAM1-4L protein renders the Madin Darby Canine Kidney cells responsive to lipopolysaccharide leading to TLR4-dependent Erk1/2 and p38 MAPK signalling.
Liévin-Le Moal V; Beau I; Rougeaux C; Kansau I; Fabrega S; Brice C; Korotkova N; Moseley SL; Servin AL
Cell Microbiol; 2011 May; 13(5):764-85. PubMed ID: 21352462
[TBL] [Abstract][Full Text] [Related]
47. Angiotensin II increases CTGF expression via MAPKs/TGF-β1/TRAF6 pathway in atrial fibroblasts.
Gu J; Liu X; Wang QX; Tan HW; Guo M; Jiang WF; Zhou L
Exp Cell Res; 2012 Oct; 318(16):2105-15. PubMed ID: 22749815
[TBL] [Abstract][Full Text] [Related]
48. [Studies on cell signaling immunomodulated murine peritoneal suppressor macrophages: LPS and PMA mediate the activation of RAF-1, MAPK p44 and MAPK p42 and p38 MAPK].
Chang ZL; Lin MQ; Wang MZ; Yao Z
Shi Yan Sheng Wu Xue Bao; 1997 Mar; 30(1):73-81. PubMed ID: 10684111
[TBL] [Abstract][Full Text] [Related]
49. Angiotensin II Induces an Increase in Matrix Metalloproteinase 2 Expression in Aortic Smooth Muscle Cells of Ascending Thoracic Aortic Aneurysms Through JNK, ERK1/2, and p38 MAPK Activation.
Wang C; Chang Q; Sun X; Qian X; Liu P; Pei H; Guo X; Liu W
J Cardiovasc Pharmacol; 2015 Sep; 66(3):285-93. PubMed ID: 25955575
[TBL] [Abstract][Full Text] [Related]
50. [Differential activation of mitogen-activated protein kinase in PC 12 cells apoptosis induced by electromagnetic irradiation].
Yang XS; Gong QF; Zhang GB; Yu ZP; Yu XD
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2005 Jun; 23(3):167-71. PubMed ID: 16124887
[TBL] [Abstract][Full Text] [Related]
51. Differential activation of the ERK, JNK, and p38 mitogen-activated protein kinases by CD40 and the B cell antigen receptor.
Sutherland CL; Heath AW; Pelech SL; Young PR; Gold MR
J Immunol; 1996 Oct; 157(8):3381-90. PubMed ID: 8871635
[TBL] [Abstract][Full Text] [Related]
52. p38 MAPK regulates phosphorylation of Bad via PP2A-dependent suppression of the MEK1/2-ERK1/2 survival pathway in TNF-alpha induced endothelial apoptosis.
Grethe S; Pörn-Ares MI
Cell Signal; 2006 Apr; 18(4):531-40. PubMed ID: 15972258
[TBL] [Abstract][Full Text] [Related]
53. Revisiting the complex influences of cannabinoids on motor functions unravels pharmacodynamic differences between cannabinoid agonists.
Bosier B; Sarre S; Smolders I; Michotte Y; Hermans E; Lambert DM
Neuropharmacology; 2010 Nov; 59(6):503-10. PubMed ID: 20633567
[TBL] [Abstract][Full Text] [Related]
54. [MIMICKING ISCHEMIC PRECONDITIONING PHENOMENON THROUGH THE IMPACT ON THE CANNABINOID RECEPTORS: ROLE OF PROTEIN KINASE AND NO-SYNTHASE].
Lishmanov YB; Maslov LN; Krylatov AV; Khaliulin IG
Ross Fiziol Zh Im I M Sechenova; 2015 Aug; 101(8):909-20. PubMed ID: 26591586
[TBL] [Abstract][Full Text] [Related]
55. Optimization of the Heterologous Expression of the Cannabinoid Type-1 (CB
Horváth VB; Soltész-Katona E; Wisniewski É; Rajki A; Halász E; Enyedi B; Hunyady L; Tóth AD; Szanda G
Front Endocrinol (Lausanne); 2021; 12():740913. PubMed ID: 34745007
[TBL] [Abstract][Full Text] [Related]
56. Improved cyclobutyl nabilone analogs as potent CB1 receptor agonists.
Papanastasiou IP; Georgiadis MO; Iliopoulos-Tsoutsouvas C; Paronis CA; Brust CA; Tran NK; Ji L; Ma X; Wood JT; Zvonok N; Tong F; Bohn LM; Nikas SP; Makriyannis A
Eur J Med Chem; 2022 Feb; 230():114027. PubMed ID: 35051750
[TBL] [Abstract][Full Text] [Related]
57. Novel endogenous peptide agonists of cannabinoid receptors.
Gomes I; Grushko JS; Golebiewska U; Hoogendoorn S; Gupta A; Heimann AS; Ferro ES; Scarlata S; Fricker LD; Devi LA
FASEB J; 2009 Sep; 23(9):3020-9. PubMed ID: 19380512
[TBL] [Abstract][Full Text] [Related]
58. Mechanisms of cannabinoid tolerance.
Piscura MK; Henderson-Redmond AN; Barnes RC; Mitra S; Guindon J; Morgan DJ
Biochem Pharmacol; 2023 Aug; 214():115665. PubMed ID: 37348821
[TBL] [Abstract][Full Text] [Related]
59. Expression of endocannabinoid system components in human airway epithelial cells: impact of sex and chronic respiratory disease status.
Fantauzzi MF; Aguiar JA; Tremblay BJ; Mansfield MJ; Yanagihara T; Chandiramohan A; Revill S; Ryu MH; Carlsten C; Ask K; Stämpfli M; Doxey AC; Hirota JA
ERJ Open Res; 2020 Oct; 6(4):. PubMed ID: 33344628
[TBL] [Abstract][Full Text] [Related]
60. The Endocannabinoid System as Pharmacological Target Derived from Its CNS Role in Energy Homeostasis and Reward. Applications in Eating Disorders and Addiction.
Viveros MP; Bermúdez-Silva FJ; Lopez-Rodriguez AB; Wagner EJ
Pharmaceuticals (Basel); 2011 Aug; 4(8):1101-1136. PubMed ID: 32143540
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
